The December Bioasis Corporate Presentation is available on the Bioasis website (thanks to Hassy over on Stockhouse for first posting). Initial focus is on in house programs xB3-001 (HER2+ breast cancer brain metastases) and xB3-007 (Gaucher’s Disease). No mention of xB3-002 program for glioblastoma in the December presentation. I'm looking forward to hearing updates on all of the programs in early January at Biotech Showcase. Hopefully lots of Buzz on Bioasis at the BIO.
BDAZ